WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999042584) APOPTOSIS INDUCING MOLECULE II AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/042584    International Application No.:    PCT/US1999/003703
Publication Date: 26.08.1999 International Filing Date: 19.02.1999
Chapter 2 Demand Filed:    17.09.1999    
IPC:
A61K 38/00 (2006.01), A61K 39/00 (2006.01), A61K 48/00 (2006.01), C07K 14/705 (2006.01)
Applicants: HUMAN GENOME SCIENCES, INC. [US/US]; 9410 Key West Avenue Rockville, MD 20850 (US) (For All Designated States Except US).
EBNER, Reinhard [DE/US]; (US) (For US Only).
YU, Guo-Liang [CN/US]; (US) (For US Only).
RUBEN, Steven, M. [US/US]; (US) (For US Only).
ZHANG, Jun [CN/US]; (US) (For US Only).
ULLRICH, Stephen [US/US]; (US) (For US Only).
ZHAI, Yifan [CN/US]; (US) (For US Only)
Inventors: EBNER, Reinhard; (US).
YU, Guo-Liang; (US).
RUBEN, Steven, M.; (US).
ZHANG, Jun; (US).
ULLRICH, Stephen; (US).
ZHAI, Yifan; (US)
Agent: STEFFE, Eric, K.; Sterne, Kessler, Goldstein & Fox P.L.L.C. Suite 600 1100 New York Avenue, N.W. Washington, DC 20005-3934 (US)
Priority Data:
60/075,409 20.02.1998 US
09/027,287 20.02.1998 US
Title (EN) APOPTOSIS INDUCING MOLECULE II AND METHODS OF USE
(FR) MOLECULE II INDUISANT L'APOPTOSE ET PROCEDES D'UTILISATION
Abstract: front page image
(EN)The present invention relates to a member of the TNF-Ligand superfamily. More specifically, isolated nucleic acid molecules are provided encoding a human Apoptosis Inducing Molecule II (AIM II). AIM II polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of AIM II activity. Also provided are therapeutic methods for treating lymphadenopathy, aberrant bone development, autoimmune and other immune system diseases, graft versus host disease, rheumatoid arthritis, osteoarthritis and to inhibit neoplasia, such as tumor cell growth.
(FR)Cette invention concerne un membre de la superfamile des ligands-TNF, et plus spécifiquement, des molécules d'acides nucléiques isolées qui codent une molécule II induisant l'apoptose chez l'homme (AIM II); des polypeptides AIM II, ainsi que des vecteurs, des cellules hôtes et des procédés de recombinaison permettant de les produire. Cette invention concerne également des procédés de criblage permettant d'identifier des agonistes et des antagonistes à l'activité de AIM II; des procédés thérapeutiques permettant de traiter la lymphadénopathie, la croissance osseuse aberrante, les maladies auto-immunes et d'autres maladies du système immunitaire, la réaction du greffon contre l'hôte, la polyarthrite rhumatoïde, l'arthrose et d'inhiber la néoplasie telle que la croissance de cellules tumorales.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)